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Background/Aims: Metabolic syndrome(MS) and its individual components are associated with nonalcoholic fatty liver disease(NAFLD) severity and progression. We sought to evaluate, in NAFLD patients discriminated by age, the effect of all components of the MS and of their combinations on the risk of severe hepatic fibrosis. 
Methods:We considered 863 consecutive biopsy-proven NAFLD patients, fully evaluated for components of MS– visceral obesity, IFG/diabetes, HDL, triglycerides and arterial hypertension. 
Results:At multivariate logistic regression analysis, F3-F4 was associated with visceral obesity(OR 20.5, 95%CI 2.29-235.9, p=0.01), IFG/diabetes(OR 2.66, 95%CI 1.76-4.04, p<0.001), and low HDL cholesterol(<40/<50 mg/dl; OR 1.73, 95%CI 1.17-2.56, p=0.006), but not triglycerides >150 or arterial hypertension. A significant interaction was found between age and visceral obesity(p=0.04). By stratifying patients for age, we confirmed the interaction between third age tertile(>54years) and visceral obesity(p=0.04). Consistently, in the lower(<41years) and middle(41-54 years) age tertiles, the risk for F3-F4 fibrosis was mostly driven by visceral obesity and IFG/diabetes, and was higher in those with all three metabolic risk factors(29% and 36% in lower and middle age tertiles, respectively). Finally, among patients in the higher age tertile(>54years), obesity did not affect fibrosis severity, and the risk of severe fibrosis was higher in those with low HDL and IFG/Diabetes with/without visceral obesity(from 52%to54%). 
Conclusions:In NAFLD, metabolic profiles at risk for severe fibrosis changed according to age, with low HDL, but mostly obesity and IFG/Diabetes being dominant in patients in lower and middle age tertiles, and HDL and IFG/Diabetes but not visceral obesity in those in the highest age tertile. 
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